glucuronyl-glucosamine-glycan-sulfate has been researched along with Necrosis* in 2 studies
2 other study(ies) available for glucuronyl-glucosamine-glycan-sulfate and Necrosis
| Article | Year |
|---|---|
[Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
To evaluate effectiveness of sulodexide in patients with pyonecrotic complications of diabetic foot.. Sulodexide was given to 15 patients which were examined for blood fibrinogen, foot tissues saturation with oxygen, microbic contamination of the wound tissue. In addition, ultrasound dopplerography of foot arteries, laser doppler flowmetry were performed.. Fibrinogen in peripheral blood fell, arteriovenous shunting diminished, capillary blood flow and oxygen saturation of the tissues improved.. Even early sulodexide treatment is effective at different stages of the pathological process in diabetic patients with severe pyonecrotic lesion of the lower limbs as it recovers microcirculatory blood flow. Topics: Diabetic Foot; Glycosaminoglycans; Humans; Hypoglycemic Agents; Microcirculation; Necrosis; Suppuration; Time Factors | 2001 |
[Sulodexide in the treatment of right hand necrosis in diabetic patient performing exchanges of continuous ambulatory peritoneal dialysis (CAPD) by himself].
The usefulness of sulodexide in the treatment of severe necrosis of right hand in 42 diabetic patient performing by himself CAPD exchanges is described. Very good results of this treatment, induced us to discuss clinical indications for this drug, which--according to our opinion--is particularly recommended for treatment of severe vascular complications in patients with diabetes and irreversible renal failure. Topics: Adult; Diabetes Mellitus, Type 1; Glycosaminoglycans; Hand; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Necrosis; Peritoneal Dialysis, Continuous Ambulatory | 1998 |